Search for: "USA v. Michael Morris" Results 1 - 20 of 63
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Nov 2021, 6:59 pm
Business and human rights: Governance challenges in an era of transition Panellists include Professor Lorna McGregor (University of Essex), Professor Morris Altman (University of Dundee), Dr Axel Marx (University of Leuven), Professor Brigit Toebes (University of Groningen) and Dr Gale Raj-Reichert (Bard College Berlin). [read post]
8 Sep 2017, 5:05 am by Jim Sedor
A USA Today shows that for the first time in U.S. history, wealthy people with interests before the government have a chance for close and confidential access to the president as a result of payments that enrich him personally. [read post]
17 Feb 2017, 12:21 pm by Amy Howe
Morris and National Labor Relations Board v. [read post]
13 Oct 2015, 3:45 am by Amy Howe
’” In an essay for the Stanford Law Review Online, Michael Pierce discusses the Court’s recent decisions in Bond v. [read post]
21 Jan 2015, 1:06 pm by Joe Consumer
  It also means that we'll have more stories like this one to look forward to: The parent company of Philip Morris USA contributed a total of $500,000 on Oct. 6 and 8 to a Republican Party group, a few weeks after the Illinois Supreme Court agreed to hear the tobacco company's appeal of a $10.1 billion verdict. [read post]
30 May 2012, 1:37 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
15 Feb 2012, 7:42 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]